Baker Brothers Advisors - ANACOR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$273,791,000
-42.3%
5,122,375
+22.0%
2.89%
-26.5%
Q4 2015$474,307,000
-2.6%
4,198,520
+1.5%
3.93%
-12.6%
Q3 2015$486,779,000
+73.4%
4,135,412
+14.1%
4.50%
+82.7%
Q2 2015$280,722,000
+15.4%
3,625,498
-13.8%
2.46%
+21.7%
Q1 2015$243,242,000
+79.4%
4,204,7020.0%2.02%
+46.2%
Q4 2014$135,602,000
+31.8%
4,204,7020.0%1.38%
+6.8%
Q3 2014$102,889,000
+78.7%
4,204,702
+29.5%
1.30%
+83.8%
Q2 2014$57,588,000
-7.0%
3,248,043
+4.9%
0.70%
-10.4%
Q1 2014$61,937,000
+47.6%
3,095,318
+23.8%
0.79%
+33.2%
Q4 2013$41,950,0002,500,0000.59%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$120,640,00041.48%
Palo Alto Investors LP 2,187,242$247,093,00013.75%
VHCP Management, LLC 140,756$15,901,0009.61%
HWG Holdings LP 48,910$5,525,0005.62%
KINGDON CAPITAL MANAGEMENT, L.L.C. 906,287$102,383,0004.98%
Baker Brothers Advisors 4,198,520$474,307,0003.93%
Asymmetry Capital Management, L.P. 15,591$1,761,0002.66%
NEXT CENTURY GROWTH INVESTORS LLC 496,744$56,117,0002.42%
AlpInvest Partners B.V. 11,551$1,305,0002.17%
Atika Capital Management LLC 36,000$4,067,0002.09%
View complete list of ANACOR PHARMACEUTICALS INC shareholders